BRAF and neoplasm: In vivo melanoma models relied on mouse models such as tumor xenografts in immunocompromised mice [7], genetically engineered mice with conditional melanocyte-specific expression of the BRAF V600E oncogene [8], or mice with induced expression of the BRAF V600E oncogene by topical application of tamoxifen [9].